Anorexia Nervosa Statistics

Anorexia nervosa (AN) is a serious and complex mental illness characterized by severe food restriction, an intense fear of gaining weight, and a distorted body image. It is not simply a diet gone too far but a life-threatening condition with profound psychological, physical, and social consequences. While often associated with being underweight, a person does not need to be medically underweight to have anorexia, and the disorder affects people of all genders, ages, races, and body sizes^[6]. Overall, approximately 9% of the U.S. population, or nearly 30 million Americans, will have an eating disorder in their lifetime^[4].

Understanding the prevalence of anorexia nervosa requires looking at different timeframes. Lifetime prevalence measures how many people will experience the disorder at any point in their lives, while 12-month prevalence reflects the number of active cases in a given year. Data from U.S. community studies show that the 12-month prevalence of anorexia in women is around 0.3% to 0.4%^[12]. This suggests that roughly one-third of individuals who have ever had anorexia are actively symptomatic in any given year^[12].

Anorexia nervosa affects people across all demographics, but certain populations face a higher risk. The disorder is strongly age-dependent, with risk peaking during adolescence and young adulthood before diminishing in older age groups^[6]. While anorexia is more commonly diagnosed in females, males are also affected, though they may be less likely to seek help due to stigma and cultural perceptions of eating disorders as a “women’s issue”^[6].

LGBTQ+ individuals, particularly transgender and nonbinary youth, face a significantly heightened risk for eating disorders. This increased vulnerability is often linked to minority stress, body dissatisfaction related to gender incongruence, and societal pressures^[6]. For example, transgender college students are over four times more likely to report an eating disorder diagnosis compared to their cisgender peers^[6]. These disparities highlight the urgent need for inclusive and affirming healthcare for this population.

The COVID-19 pandemic had a profound impact on mental health, leading to a significant increase in eating disorder diagnoses. During the pandemic, there was an overall 15.3% increase in new eating disorder diagnoses compared to previous years^[22]. This surge was particularly pronounced among adolescent females, driven by factors such as social isolation, disruption of routines, and increased social media use. The data reveals a clear spike in prevalence rates during the peak pandemic years, which have since begun to level off but remain elevated compared to pre-pandemic baselines.

Despite the severity of anorexia nervosa, a vast majority of individuals do not receive the care they need. The path to treatment is often blocked by numerous obstacles, including financial hardship, geographic limitations, and stigma. Research shows that 96% of treatment seekers face at least one barrier, with an average of three distinct barriers per person^[6]. These challenges contribute to a median treatment delay of 2.5 years after symptom onset, a critical period where early intervention could significantly improve outcomes^[23].

While anorexia is a challenging illness, recovery is possible with evidence-based treatment. For adolescents, Family-Based Treatment (FBT) is considered the gold standard. For adults, psychotherapies like Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) are key options^[5]. The emergence of telehealth has also proven to be an effective and acceptable alternative to in-person care, helping to reduce wait times and improve access^[26]. However, even with treatment, dropout and relapse rates remain a concern.

The economic impact of anorexia nervosa extends far beyond direct healthcare costs, affecting individuals, families, employers, and society as a whole. The total annual economic burden of all eating disorders in the U.S. is estimated at $64.7 billion^[8]. Anorexia alone contributes significantly to this total, with costs stemming from medical care, lost productivity, and reduced quality of life. These figures underscore the importance of investing in prevention and effective treatment to mitigate long-term financial consequences.

Anorexia nervosa has the second-highest mortality rate of any psychiatric illness, surpassed only by opioid use disorder^[6]. The causes of death are often due to medical complications such as cardiac arrest or suicide. The risk of suicide is exceptionally high in this population, with individuals facing a risk of death by suicide up to 18 times higher than their peers without an eating disorder^[30]. This elevated risk is compounded by high rates of comorbid conditions like depression, anxiety, and substance use disorders.